Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol (22 mEq K+) Total Approximate Volume 255 mL, Rx only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0841-32
Published July 19, 2017 · Recall initiated: June 21, 2017
Summary
FDA records drug Class II recall D-0978-2017, published July 19, 2017 and initiated June 21, 2017. Recalling firm: SCA Pharmaceuticals; Status: Terminated; Reported quantity: 20 bags; Lot: Lot #: 20170602@29, Exp 7/17/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of sterility assurance
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- SCA Pharmaceuticals
- Distributor
- LA, PA, NY, WI
- Lot
- Lot #: 20170602@29, Exp 7/17/2017
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFentaNYL 500 mcg/250 mL - Bupivacaine HCl 0.1% in 0.9% Sodium Chloride 250mL Bag, Injection for Epidural UseAugust 2, 2023
- FDAOxytocin 30 units added to 0.9% Sodium Chloride 500 mL, Rx Only, Single Dose Container, SCA Pharmaceuticals,May 3, 2023
- FDAFentanyl 1,500 mcg/30 mL syringe, Injection for Intravenous Use, Concentration = 50 mcg/mL, Preservative Free,March 8, 2023
- FDANorepinephrine 8mg in 0.9% Sodium Chloride 250 mL bag, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDCMay 11, 2022
- FDAPotassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol (22 mEq K+) Total Approximate Volume 255 mL,July 19, 2017
- FDAPotassium PHOSphate added to 0.9% Sodium Chloride 250 mL Bag 30 mMol (44 mEq K+) Total Approximate Volume 260July 19, 2017
Questions about this recall
Was Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol (22 mEq K+) Total Approximate Volume 255 mL, Rx only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0841-32 recalled?
Yes. FDA published recall D-0978-2017 on July 19, 2017. Reported hazard: Lack of sterility assurance
What should I do if I have this product?
Voluntary: Firm initiated · Letter